Request for Covid-19 Impact Assessment of this Report

Take Action
Diagnostic and Biotech

Global Healthcare Nanotechnology (Nanomedicine) Market Size study, by Diseases (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases and Others), Application (Drug Delivery, Biomaterials, Active Implants and Others) and Regional Forecasts 2020-2027

  • BIZ4192959
  • 200 Pages
  • February 2021
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Global Healthcare Nanotechnology (Nanomedicine) Market is valued approximately USD 196.47 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9 % over the forecast period 2020-2027. Healthcare Nanotechnology (Nanomedicine) is the product which is nano-formulations of the existing drugs or new drugs or nanomaterials. Nanomedicine helps in improving human health by providing solutions for various life-threatening diseases, like cancer, Parkinson’s disease, Alzheimer’s disease, diabetes, orthopedic diseases, and infections blood, lungs, and cardiovascular system. For instance: according to the Alzheimer's Disease International, there were around 50 million people globally with dementia in 2020, which is expected to double every 20 years. According to the Globocan 2020, the global cancer burden increased to 19.3 million cases and 10 million cancer deaths in 2020. This will increase the demand for effective nanomedicines in the management of the diseases. Further, increasing investments in urgent care, increasing geriatric population and strategic development between hospitals and the manufacturers has led the adoption of Healthcare Nanotechnology (Nanomedicine) across the forecast period. The market has seen positive growth due to investments in new products by research & development. For Instance: in 2020, Medtronic PLC launched navigated titanium spinal implant, its new Adaptix Interbody System which is with the Titan nanoLOCK Surface Technology. In 2019, Nanobiotix, a clinical stage nanomedicine company had obtained the CE approval for its Hensify (NBTXR3), nanoparticles designed for injection directly into a tumor. However, stringent regulatory issues and high cost of nano-medicines compared to the traditional medicines along with low awareness among consumers in low income countries impedes the growth of the market over the forecast period of 2020-2027. Also, with the increasing prevalence of diseases, technological advancements for early disease diagnosis & preventive intervention the adoption & demand for Healthcare Nanotechnology (Nanomedicine) is likely to increase.

The regional analysis of global Healthcare Nanotechnology (Nanomedicine) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of nano-medicines coupled with the well-established healthcare infrastructure along with the huge investments in research & development activities. For instance: according to the www.acc.org, in 2018, coronary heart disease was the leading cause of deaths attributable to cardiovascular disease in the United States with 43.8% of total CVD deaths. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rise in research grants, increasing venture capital investors from developing economies of this region and increasing international research collaborations along with the improving healthcare infrastructure would create lucrative growth prospects for the Healthcare Nanotechnology (Nanomedicine) market across Asia-Pacific region.

Major market player included in this report are:

Abbott Laboratories

CombiMatrix Corporation

GE Healthcare

Sigma-Tau Pharmaceuticals, Inc.

Johnson & Johnson

Mallinckrodt plc

Merck & Company, Inc.

Nanosphere, Inc.

Pfizer, Inc.

Celgene Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diseases:

Cardiovascular Diseases

Oncological Diseases

Neurological Diseases

Others

By Application:

Drug Delivery

Biomaterials

Active Implants

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Healthcare Nanotechnology (Nanomedicine) Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Healthcare Nanotechnology (Nanomedicine) Market, by Region, 2018-2027 (USD Billion)

1.2.2. Healthcare Nanotechnology (Nanomedicine) Market, by Diseases, 2018-2027 (USD Billion)

1.2.3. Healthcare Nanotechnology (Nanomedicine) Market, by Application, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Healthcare Nanotechnology (Nanomedicine) Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Healthcare Nanotechnology (Nanomedicine) Market Dynamics

3.1. Healthcare Nanotechnology (Nanomedicine) Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Healthcare Nanotechnology (Nanomedicine) Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Healthcare Nanotechnology (Nanomedicine) Market, by Diseases

5.1. Market Snapshot

5.2. Global Healthcare Nanotechnology (Nanomedicine) Market by Diseases, Performance - Potential Analysis

5.3. Global Healthcare Nanotechnology (Nanomedicine) Market Estimates & Forecasts by Diseases 2017-2027 (USD Billion)

5.4. Healthcare Nanotechnology (Nanomedicine) Market, Sub Segment Analysis

5.4.1. Cardiovascular Diseases

5.4.2. Oncological Diseases

5.4.3. Neurological Diseases

5.4.4. Others

Chapter 6. Global Healthcare Nanotechnology (Nanomedicine) Market, by Application

6.1. Market Snapshot

6.2. Global Healthcare Nanotechnology (Nanomedicine) Market by Application, Performance - Potential Analysis

6.3. Global Healthcare Nanotechnology (Nanomedicine) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)

6.4. Healthcare Nanotechnology (Nanomedicine) Market, Sub Segment Analysis

6.4.1. Drug Delivery

6.4.2. Biomaterials

6.4.3. Active Implants

6.4.4. Others

Chapter 7. Global Healthcare Nanotechnology (Nanomedicine) Market, Regional Analysis

7.1. Healthcare Nanotechnology (Nanomedicine) Market, Regional Market Snapshot

7.2. North America Healthcare Nanotechnology (Nanomedicine) Market

7.2.1. U.S. Healthcare Nanotechnology (Nanomedicine) Market

7.2.1.1. Diseases breakdown estimates & forecasts, 2017-2027

7.2.1.2. Application breakdown estimates & forecasts, 2017-2027

7.2.2. Canada Healthcare Nanotechnology (Nanomedicine) Market

7.3. Europe Healthcare Nanotechnology (Nanomedicine) Market Snapshot

7.3.1. U.K. Healthcare Nanotechnology (Nanomedicine) Market

7.3.2. Germany Healthcare Nanotechnology (Nanomedicine) Market

7.3.3. France Healthcare Nanotechnology (Nanomedicine) Market

7.3.4. Spain Healthcare Nanotechnology (Nanomedicine) Market

7.3.5. Italy Healthcare Nanotechnology (Nanomedicine) Market

7.3.6. Rest of Europe Healthcare Nanotechnology (Nanomedicine) Market

7.4. Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Snapshot

7.4.1. China Healthcare Nanotechnology (Nanomedicine) Market

7.4.2. India Healthcare Nanotechnology (Nanomedicine) Market

7.4.3. Japan Healthcare Nanotechnology (Nanomedicine) Market

7.4.4. Australia Healthcare Nanotechnology (Nanomedicine) Market

7.4.5. South Korea Healthcare Nanotechnology (Nanomedicine) Market

7.4.6. Rest of Asia Pacific Healthcare Nanotechnology (Nanomedicine) Market

7.5. Latin America Healthcare Nanotechnology (Nanomedicine) Market Snapshot

7.5.1. Brazil Healthcare Nanotechnology (Nanomedicine) Market

7.5.2. Mexico Healthcare Nanotechnology (Nanomedicine) Market

7.6. Rest of The World Healthcare Nanotechnology (Nanomedicine) Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Abbott Laboratories

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. CombiMatrix Corporation

8.2.3. GE Healthcare

8.2.4. Sigma-Tau Pharmaceuticals, Inc.

8.2.5. Johnson & Johnson

8.2.6. Mallinckrodt plc

8.2.7. Merck & Company, Inc.

8.2.8. Nanosphere, Inc.

8.2.9. Pfizer, Inc.

8.2.10. Celgene Corporation

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Healthcare Nanotechnology (Nanomedicine) market, report scope

TABLE 2. Global Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by Region 2017-2027 (USD Billion)

TABLE 3. Global Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by Diseases 2017-2027 (USD Billion)

TABLE 4. Global Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by Application 2017-2027 (USD Billion)

TABLE 5. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 6. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 7. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global Healthcare Nanotechnology (Nanomedicine) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global Healthcare Nanotechnology (Nanomedicine) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. U.S. Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. U.S. Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 17. U.S. Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 18. Canada Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. Canada Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 20. Canada Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 21. UK Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 22. UK Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 23. UK Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 24. Germany Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 25. Germany Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 26. Germany Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 27. RoE Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 28. RoE Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 29. RoE Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 30. China Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 31. China Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 32. China Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 33. India Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 34. India Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 35. India Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 36. Japan Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 37. Japan Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 38. Japan Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 39. RoAPAC Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 40. RoAPAC Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 41. RoAPAC Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 42. Brazil Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 43. Brazil Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 44. Brazil Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 45. Mexico Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 46. Mexico Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 47. Mexico Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 48. RoLA Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 49. RoLA Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 50. RoLA Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 51. Row Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 52. Row Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 53. Row Healthcare Nanotechnology (Nanomedicine) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 54. List of secondary sources, used in the study of global Healthcare Nanotechnology (Nanomedicine) market

TABLE 55. List of primary sources, used in the study of global Healthcare Nanotechnology (Nanomedicine) market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research